Healthcare -
Biotechnology - NASDAQ - US
$ 0.6601
-5.47 %
$ 83.3 M
Market Cap
-0.63
P/E
KPTI - REVENUE
Revenue KPTI - Karyopharm Therapeutics Inc.
146 M
LAST VALUE
-16.57%
2 YEAR CAGR
36.93%
5 YEAR CAGR
81.00%
10 YEAR CAGR